-
Signature
-
/s/ Douglas Barry, Attorney-in-Fact
-
Stock symbol
-
KNSA
-
Transactions as of
-
Oct 31, 2025
-
Transactions value $
-
-$2,520,570
-
Form type
-
4
-
Date filed
-
11/4/2025, 04:36 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Paolini John F. |
CHIEF MEDICAL OFFICER |
105 PICCADILLY, SECOND FLOOR, LONDON, UNITED KINGDOM |
/s/ Douglas Barry, Attorney-in-Fact |
2025-11-04 |
0001741533 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
KNSA |
Class A Ordinary Share |
Options Exercise |
$139K |
+36.5K |
+59.59% |
$3.80 |
97.9K |
Oct 31, 2025 |
Direct |
F1 |
| transaction |
KNSA |
Class A Ordinary Share |
Options Exercise |
$406K |
+46K |
+47% |
$8.83 |
144K |
Oct 31, 2025 |
Direct |
F1 |
| transaction |
KNSA |
Class A Ordinary Share |
Sale |
-$3.07M |
-82.5K |
-57.37% |
$37.14 |
61.3K |
Oct 31, 2025 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
KNSA |
Share Option |
Options Exercise |
$0 |
-36.5K |
-100% |
$0.00 |
0 |
Oct 31, 2025 |
Class A Ordinary Share |
36.5K |
$3.80 |
Direct |
F1, F3 |
| transaction |
KNSA |
Share Option |
Options Exercise |
$0 |
-46K |
-100% |
$0.00 |
0 |
Oct 31, 2025 |
Class A Ordinary Share |
46K |
$8.83 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: